Physician profile
Michael J Korman
NPI 1316950132
$5,309.75
in general payments reported to CMS, 2019-2025
16 companies · $232 in 2025
The $232 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $678 · 2020: $3,727 · 2021: $298 · 2022: $107 · 2023: $154 · 2024: $114 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $4,238.14 | 2019-2025 | Nucala |
| Novartis Pharmaceuticals Corporation | $263.24 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.97 | 2019-2021 | |
| Genentech USA, INC. | $145.66 | 2019 | |
| Genzyme Corporation | $124.18 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $60.91 | 2019-2022 | |
| Verona Pharma, INC. | $57.02 | 2025 | Ohtuvayre |
| Philips North America LLC | $56.29 | 2019-2020 | |
| Mylan Specialty L.P. | $41.77 | 2019-2020 | |
| Insmed, INC. | $32.16 | 2023 | Arikayce |
| Amgen INC. | $26.93 | 2023 | Tezspire |
| Pulmonx Corporation | $25.03 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Regeneron Healthcare Solutions, INC. | $19.36 | 2023 | Dupixent |
| Pfizer INC. | $16.79 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $15.49 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Circassia INC. | $14.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Korman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.